Sign in
4

Changes in Ownership

Ascendis Pharma A/S Filed Acc 0001610717-26-000177

Director bought 500 shares at an average $223.12 ($111,562)

From the SEC's structured data for this filing

Trades in this filing

BIENAIME JEAN JACQUES · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-29 Purchase : show line 1 in the form +200 $223.76 $44,752 600 D
2026-05-29 Purchase : show line 2 in the form +200 $222.30 $44,460 800 D
2026-05-29 Purchase : show line 3 in the form +100 $223.50 $22,350 900 D
Open-market purchases · 500 sh · avg $223.12 · $111,562
Loading xslF345X06/form4.xml…